Clinical Research Directory
Browse clinical research sites, groups, and studies.
JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance
Sponsor: AbbVie
Summary
The cumulative effects of aging, weight change, ergonomics (i.e., "tech neck"), and environmental exposures (i.e., ultraviolet, infrared, and visible light radiation and pollution) leads to wrinkles, discoloration, laxity, and roughness of sun exposed skin. The neck is a frequently mentioned area by patients complaining about its crepey texture and deep lines. VOLITE XC is a crosslinked hyaluronic acid (HA) gel implant formulated with lidocaine that was developed to provide a safe, minimally invasive method of treating fine lines and improving skin smoothness. The purpose of this study is to assess safety and effectiveness of VOLITE XC in adults seeking improvement in neck appearance. VOLITE XC is an investigational product intended to reduce horizontal neck lines for improvement of neck appearance. Participants are placed in 1 of 2 groups, called treatment arms. Participation will be randomized in a 2:1 ratio in treatment and control arms. Up to 212 adult participants with moderate or severe transverse neck lines will be enrolled in the study at up to 20 sites. Participants in the treatment group will receive VOLITE XC at Day 1 and be followed for up to 14 Months. Participants will have the opportunity to receive optional touch-up and optional repeat treatment of VOLITE XC during the follow-up duration period. The control group received no treatment and will be followed for up to 6 months after randomization. Participants can then opt to receive VOLITE XC and be followed for 6 Months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, checking for side effects, and completing questionnaires.
Official title: Multicenter, Evaluator-blinded, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
159
Start Date
2022-05-02
Completion Date
2024-09-12
Last Updated
2026-09-03
Healthy Volunteers
No
Conditions
Interventions
VOLITE XC
Intradermal Injection
VOLITE XC
Subdermal Injection
Locations (15)
Steve Yoelin MD Medical Associate Inc /ID# 239072
Newport Beach, California, United States
Laser & Skin surgery Medical group, Inc /ID# 241999
Sacramento, California, United States
Cosmetic Laser Dermatology /ID# 239121
San Diego, California, United States
Art of Skin MD /ID# 239071
Solana Beach, California, United States
Center for Dermatology and Dermatologic Surgery /ID# 239137
Washington D.C., District of Columbia, United States
Hevia Cosmetic Dermatology /ID# 239118
Coral Gables, Florida, United States
Skin Research Institute LLC /ID# 239109
Coral Gables, Florida, United States
Research Institute of the Southeast, LLC /ID# 239070
West Palm Beach, Florida, United States
Delricht Research /ID# 242001
New Orleans, Louisiana, United States
Rkmd, Llc /Id# 239075
North Bethesda, Maryland, United States
image Dermatology, P.C. /ID# 239136
Montclair, New Jersey, United States
Skin And Aesthetics Surgery Of Manhattan /ID# 243607
New York, New York, United States
Mariwalla Dermatology /ID# 239102
West Islip, New York, United States
Aesthetic Solutions /ID# 239074
Chapel Hill, North Carolina, United States
Bellaire Dermatology Associates /ID# 239133
Bellaire, Texas, United States